AGTR2 and Stroke: Indeed, it has been shown that central administration of CGP42112A increases neuronal survival and minimizes experimental post-stroke injury (McCarthy et al., 2009), indicating that activation of brain AT2 receptors exhibits a neuroprotective effect.